Segun Fatumo

• Professor and Chair of Genomic Diversity, Queen Mary University of London

Professor Segun Fatumo is a globally recognised genomic epidemiologist and one of the leading voices advancing equitable human genomics research. With more than two decades of experience, he has made transformative contributions to understanding the genetic determinants of a range of non-communicable diseases (NCDs), including chronic kidney disease and cardiometabolic traits in diverse ancestry populations.

He is Professor and Chair of Genomic Diversity at Queen Mary University of London and Head of Non-Communicable Disease Genomics at the MRC Uganda Research Unit, where he leads pioneering cross-continental research programmes. His academic foundation includes a PhD in Bioinformatics, supported by advanced postdoctoral training in bioinformatics and genetic epidemiology at the University of Georgia (USA), the University of Cambridge, and the Wellcome Sanger Institute (UK).

Professor Fatumo is widely known for his leadership in large-scale genomic initiatives aimed at addressing global health inequalities. He is the Principal Investigator and co-director of major continental programmes such as KidneyGenAfrica, BCX-Africa, and co-lead the Nigerian 100K Genome Project - A concerted effort to see over 100,000 Nigerians participate in the eponymous study, which will seek to understand the genetic basis of the highly prevalent NCDs in Nigeria. His work has attracted multi-million-dollar funding from the MRC, NIH, Wellcome Trust, and other global funders. Through these initiatives, he has been instrumental in establishing genomic research infrastructure, training early-career scientists, and driving capacity building across Africa.

A respected public communicator and global science ambassador, Professor Fatumo has been featured in major international media outlets, including BBC, The Telegraph, WIRED, Science Magazine, Forbes and others. He is frequently invited to deliver keynote lectures and expert invited presentations at leading scientific conferences around the world. He also serves as an Associate Editor for high-impact journals such as Genome Medicine and BMC Medical Genomics.

MENAFN09042026000199003603ID1110964465